UB
LGND icon

UMB Bank’s Ligand Pharmaceuticals LGND Stock Holding History

UMB Bank’s Portfolio LGND Stock Details LGND Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$32.6K Buy
103
+9
+10% +$2.12K ﹤0.01% 1490
2026
Q1 		$18.8K Buy
94
+5
+6% +$989 ﹤0.01% 1628
2025
Q4 		$16.8K Buy
89
+13
+17% +$2.5K ﹤0.01% 1621
2025
Q3 		$13.5K Buy
76
+15
+25% +$2.23K ﹤0.01% 1565
2025
Q2 		$6.93K Sell
61
-13
-18% -$1.39K ﹤0.01% 1726
2025
Q1 		$7.78K Buy
74
+27
+57% +$3.05K ﹤0.01% 1626
2024
Q4 		$5.04K Hold
47
– – ﹤0.01% 1704
2024
Q3 		$4.7K Buy
47
+20
+74% +$2.01K ﹤0.01% 1749
2024
Q2 		$2.27K Buy
27
+19
+238% +$1.51K ﹤0.01% 1726
2024
Q1 		$585 Buy
+8
New +$590 ﹤0.01% 1937
2022
Q1 		– Sell
-10
Closed -$1K – 2032
2021
Q4 		$1K Buy
+10
New +$924 ﹤0.01% 1926

Other funds holding LGND

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JT
Jupiter Topco New York $245B AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

UMB Bank's LGND Position: Q2 2026 in Review

UMB Bank increased its Ligand Pharmaceuticals (LGND) stake by 9.6% in Q2 2026, buying an estimated $2.12K and bringing the position to 103 shares worth $32.6K. The position accounts for ﹤0.01% of the portfolio, ranked #1490.

UMB Bank first reported a position in LGND in Q4 2021 and has held it in 11 quarters since. 414 funds tracked by Wall St. Rank hold LGND as of Q2 2026.

  • UMB Bank held 103 shares of Ligand Pharmaceuticals worth $32.6K as of Q2 2026.
  • UMB Bank bought 9 Ligand Pharmaceuticals shares in Q2 2026, an estimated $2.12K.
  • Ligand Pharmaceuticals made up ﹤0.01% of UMB Bank's portfolio in Q2 2026, its #1490 holding.
  • UMB Bank first reported a position in Ligand Pharmaceuticals in Q4 2021 and has held it in 11 quarters since.
  • 414 funds tracked by Wall St. Rank held Ligand Pharmaceuticals as of Q2 2026.

Based on UMB Bank's 13F filing for Q2 2026, filed 13 Aug 2026.